Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Most Shorted Stocks
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Investors
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Careers
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
MCP for Agents
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Most Shorted Stocks
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Center
Investors
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
ELDN
Stock Latest News
The Fly
Eledon files islet cell transplant application, plans Phase 3 kidney trial
11d ago
ELDN
Premium
The Fly
Eledon Pharmaceuticals reports Q2 EPS (27c), consensus (15c)
29d ago
ELDN
Premium
Ratings
Eledon Therapeutics: Buy Rating Reaffirmed on Strong Cash Runway and Tegoprubart Data; Price Target Unchanged at $8
1M ago
ELDN
Premium
Company Announcements
Eledon’s BESTOW Trial Completion: What Tegoprubart Could Mean for Transplant Investing
2M ago
ELDN
Premium
The Fly
Eledon Pharmaceuticals initiated with a Buy at Rodman & Renshaw
2M ago
ELDN
Premium
The Fly
NewcelX completes Type B Pre-IND meeting with FDA for NCEL-101
3M ago
ELDN
NCEL
Premium
The Fly
Natera, Eledon announce strategic partnership
3M ago
ELDN
NTRA
Premium
Company Announcements
Eledon Pharmaceuticals Expands Authorized Shares After Stockholder Vote
3M ago
8K
ELDN
Premium
The Fly
Eledon Pharmaceuticals announces new long-term data from BESTOW program
3M ago
ELDN
Premium
Ratings
Analyst Reiterates Buy on Eledon as Tegoprubart Data Impresses; Price Target Maintained at $6
3M ago
ELDN
Premium
The Fly
Eledon Pharmaceuticals announces updated results from tegoprubart trial
3M ago
ELDN
Premium
The Fly
NewcelX submits NCEL-101 pre-investigational new drug briefing package to FDA
4M ago
ELDN
NCEL
Premium
The Fly
Eledon Pharmaceuticals reports Q1 EPS (33c), consensus (23c)
4M ago
ELDN
Premium
The Fly
Eledon Pharmaceuticals files $500M mixed securities shelf
5M ago
ELDN
Premium
The Fly
NewcelX announces release of updated presentation on Type 1 Diabetes program
5M ago
ELDN
NCEL
Premium
The Fly
Eledon Pharmaceuticals options imply 11.7% move in share price post-earnings
6M ago
ELDN
Premium
Pre-Earnings
Eledon Pharmaceuticals, Inc. (ELDN) Q4 Earnings Cheat Sheet
6M ago
ELDN
Premium
Ratings
Compelling Tegoprubart Data in Type 1 Diabetes Transplantation Support Buy Rating on Eledon
6M ago
ELDN
Premium
The Fly
Eledon announces updated data from islet transplant trial of tegoprubart
6M ago
ELDN
Premium
The Fly
Eledon Pharmaceuticals announces U.S. FDA granted ODD to tegoprubart
6M ago
ELDN
Premium
The Fly
NewcelX announces research agreement with Eledon Pharmaceuticals
6M ago
ELDN
NCEL
Premium
Ratings
Eledon Pharmaceuticals: Sustained Tegoprubart Efficacy, Differentiated Safety, and Upcoming Transplant Catalysts Support Buy Rating
8M ago
ELDN
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
